Pierre Fabre has been a major player in dermatology for over 40 years and has had over 45 years of experience in the pharmaceutical industry. Pierre Fabre's rigor and pharmaceutical know how shines in top expertise in research and development, offering scientific solutions that guarantee optimal tolerance and efficacy. Health and safety are at the core of all of Pierre Fabre’s formulations. Research, innovation, ethical and pharmaceutical rigour, a commitment to public health, scientific cosmetics of the highest level. It is thanks to these strong values, cultivated by the firm for over…
About Pharma Consult GlobalPharma Consult Global is your Preferred Partner for providing a quality solution for technical support services to the pharmaceutical industry.We were formed in 2013 Pharma Consult Global Ltd by four leading International Pharmaceutical Specialists, to provide best practices standards in pharmaceutical science and technical support to Pharmaceutical Companies globally and, particularly, to those operating in the emerging markets.Our highly qualified team has an outstanding track record of delivering successful projects across the following areas:Product…
NormOxys, Inc., is a biotechnology company developing a new class of small molecule drugs which are derivatives of polyol phosphates. This platform promises to offer breakthrough treatments for a wide variety of cancers.
Epione Biopharmaceuticals was formed to provide the benefits of highly efficacious, injectable medications for the treatment of pain in multiple markets without the burden and risks that opiate-based therapies offer. The worldwide incidence of acute and chronic pain, and the growing occurrence of migraine have lead to widespread consequences for both the healthcare system and the economy. First-line pain treatments are typically opiate-based medications; however, concerns regarding side effects, prescription drug abuse, risk of overdose, patient non-adherence to treatment regimens…
Venture Development FirmInnovation TechnologyVenture Capital FormationStrategic Growth & RelationsAgile Accelerated DevelopmentBiotech, Life Science, Medical Device, Food/Agri/Aqua, Controls/Instruments, Software/Data, Cleantech
Versante International, LLC is a leader in providing Biometrics related services to the Pharmaceutical and Biotech clinical development stage companies. Our team of proven experts in Biostatistics, SAS Programming and Data Management has extensive experience across a wide range of therapeutic areas. Work with Versante and benefit from shorter development times, enhanced product quality and reduced regulatory review cycles.
Solid international business leader in small, mid, and large organizations. Significant global operations and business development expertise ranging from an early relationship initiation phase through culmination in a win win outcome. Strategic thinker with demonstrated execution experience with favorable P&L impact. Multilingual. Innovative.
Suntec Corporation was established in 2005 in Southern California, USA. We engage in the business of biotech, medical device and drug development. With a few years of perseverance and persistence, we have experienced rapid growth and significant success in global leadership of pharmaceutical markets.
VBI Vaccines Inc. (Nasdaq: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus. The company’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine; VBI has initiated work for GMP manufacturing of its CMV candidate for use in formal preclinical and Phase I trials. The company’s second platform is a thermostable technology that enables the…
Neuronasal develops drugs, delivered intranasally, for acute brain injuries. Our first products are for concussion. Neuronasal was founded to create value for patients and investors by licensing and developing drugs to treat acute brain injuries and disease. We plan to develop each of our drugs to proof of concept and then enter into strategic partnerships or trade sales. Neuronasal’s first two products are repurposed off patent drugs, deferoxamine and N acetyl cysteine, that we will deliver with existing intranasal delivery devices in clinical trials for concussion and intracerebral…
We are engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Controlled-release means releasing a drug into the bloodstream or at a target site in the body, over an extended period of time or at predetermined times. In some circumstances, controlled-release drug delivery can enhance efficacy and patient compliance as compared to immediate release formats for the same drug.Our proprietary Hypermatrix™ technology is at the core of our controlled-release drug delivery approach. The flexibility of the Hypermatrix™ technology…
MediNatura is dedicated to manufacturing and distributing high quality, FDA regulated products. We know people can improve their lives by making healthy lifestyle choices, healthy food choices and healthy medicine choices. MediNatura's mission is to improve lives with medicines from nature.
Alba Biologics Group is a leading biopharmaceutical strategic and technical support group providing consulting and management services to start-ups, early product developers and established industry leaders. With 20 years experience Alba Biologics leverages the expertise of the founder and our associates to help clients advance drug candidates from the bench through to regulatory approval. Alba will support client organizations on both short and long term projects working with a clientпїЅs in house staff as well as integrating with contract service providers.Alba Biologics brings to the…
Barnes Healthcare Services was founded in 1909 by Charles W. Barnes, Rph. in a corner drug store in Valdosta, Georgia. In those days medications were compounded by hand and the horse was the main mode of transportation. In 1946 Barnes supplied its first patient with a hospital bed, oxygen and a wheelchair. The business has been passed down through three generations to Charles W. Barnes, III whose vision, dedication to the patient, and desire to be the best provider in the area has grown the business to 21 locations in Georgia, Florida, and Alabama.
Alpha Cancer Technologies Inc., (ACT) is a private clinical stage biotechnology company with products under development in oncology and auto-immune disease indications. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP) with unique immuno-oncology properties.One of the largest US biotech companies recently purchased a 14% equity stake in ACT for US $7.5 million as part of a larger financing with institutional and private investors.
QUADRAS is a global provider of unique, enterprise-class Data Collection and Professional Service solutions, with a specialization in mobile data capture and RFID technologies. Our business solutions are focused on optimizing operations, reducing expenses, and improving business processes, and they have successfully been applied across a wide range of industries.As recognized leaders in the Data Collection, RFID, and EAM/IT Consulting fields, we stand behind our know-how, our recommendations, and our implementations - we will execute what we promise and help you attain your key performance…
The biggest unmet medical need is to provide safe and efficacious drugs to the patient. However, the pharmaceutical industry is currently facing a litany of challenges, including but not limited to: 1) lead identification; 2) lead optimization & prioritization; 3) predicting side effects and toxicity; 4) meeting efficacy requirements; 5) maximizing patent life on the market; and 6) product rescue/repositioning. As a result, R&D success rates are falling, and R&D spending is not contributing to increased sales. According to research by Jack Scannell published in Nature, “...the number of new…
Auritec Pharmaceuticals, Inc. is a research and development (R&D) company, specializing in innovative, extended release drug delivery systems. Auritec was founded by Thomas J. Smith, MD. Dr. Smith was previously Medical Director and Chairman at Control Delivery Systems, Inc. (CDS), where he was the co-founder and PI on key patents. CDS, now Psivida Inc. (NASDQ - PSDV), is a successful device company specializing in ophthalmic extended release therapies. Dr. Smith is joined on Auritec's management team by Gary Ransom, a seasoned international business executive, who focuses on strategy,…
ProNAi Therapeutics is a drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology drug development company oriented towards registration and commercialization. We have a world-class management team with a proven track record of success in oncology drug development and we intend to build a broad and diverse pipeline of promising oncology assets against emerging targets on the leading edge of cancer biology.
Creabilis is a clinical-stage, specialty pharmaceutical company focusing on the development of innovative, first-in-class topical treatments in the field of dermatology. The Company’s lead product, CT327, is a Phase III-ready topical treatment for chronic pruritus (itch), which the Company believes is the most advanced, novel, topical treatment in development for the indication. Pruritus is a debilitating symptom of many dermatological diseases, with a significant negative impact on a patient’s quality of life.
